Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
2024-11-22 Purchase | 2024-11-26 4:15 pm | Verrica Pharmaceuticals Inc. | VRCA | Rieger Jayson CEO and President | 280,898 | $0 | $0 | 1,170,779 (Indirect Direct) | View |
2024-11-22 Purchase | 2024-11-26 4:15 pm | Verrica Pharmaceuticals Inc. | VRCA | Stalfort John A III Director | 1,123,595 | $0 | $0 | 2,997,394 (Direct) | View |
2024-11-22 Purchase | 2024-11-26 4:15 pm | Verrica Pharmaceuticals Inc. | VRCA | Manning Paul B Director 10% Owner | 22,921,348 | $0 | $0 | 60,982,127 (Indirect Direct) | View |
2024-08-26 Sale | 2024-08-28 4:15 pm | Verrica Pharmaceuticals Inc. | VRCA | Hayes Christopher G. CHIEF LEGAL OFFICER | 35,713 | $2.6066 | $93,091 | 105,773 (Direct) | View |
2024-08-26 Sale | 2024-08-28 4:15 pm | Verrica Pharmaceuticals Inc. | VRCA | Goldenberg Gary Chief Medical Officer | 13,489 | $2.6066 | $35,161 | 94,261 (Direct) | View |
2024-08-26 Sale | 2024-08-28 4:15 pm | Verrica Pharmaceuticals Inc. | VRCA | Bonaccorso Joe CHIEF COMMERCIAL OFFICER | 33,702 | $2.6066 | $87,849 | 73,114 (Direct) | View |
2024-08-26 Sale | 2024-08-28 4:15 pm | Verrica Pharmaceuticals Inc. | VRCA | Kohler Terry CHIEF FINANCIAL OFFICER | 29,719 | $2.6068 | $77,473 | 44,697 (Direct) | View |
2024-08-26 Sale | 2024-08-28 4:15 pm | Verrica Pharmaceuticals Inc. | VRCA | White Ted PRESIDENT AND CEO | 34,000 | $2.6069 | $88,636 | 215,967 (Direct) | View |
2024-07-22 Sale | 2024-07-23 6:13 pm | Verrica Pharmaceuticals Inc. | VRCA | White Ted PRESIDENT AND CEO | 32,623 | $7.0596 | $230,306 | 249,967 (Direct) | View |
2024-07-22 Sale | 2024-07-23 6:12 pm | Verrica Pharmaceuticals Inc. | VRCA | Bonaccorso Joe CHIEF COMMERCIAL OFFICER | 25,576 | $7.0596 | $180,557 | 106,816 (Direct) | View |
2024-07-22 Sale | 2024-07-23 6:11 pm | Verrica Pharmaceuticals Inc. | VRCA | Goldenberg Gary Chief Medical Officer | 18,507 | $7.0596 | $130,653 | 107,750 (Direct) | View |
2024-07-22 Sale | 2024-07-23 6:10 pm | Verrica Pharmaceuticals Inc. | VRCA | Hayes Christopher G. CHIEF LEGAL OFFICER | 21,740 | $7.0597 | $153,477 | 141,486 (Direct) | View |
2023-12-27 Purchase | 2023-12-29 5:27 pm | Verrica Pharmaceuticals Inc. | VRCA | PERCEPTIVE ADVISORS LLC PERCEPTIVE LIFE SCIENCES MASTER FUND LTD EDELMAN JOSEPH 10% Owner | 321,616 | $7.1673 | $2,305,132 | 7,099,182 (Indirect) | View |
2023-12-21 Purchase | 2023-12-26 7:21 pm | Verrica Pharmaceuticals Inc. | VRCA | PERCEPTIVE ADVISORS LLC PERCEPTIVE LIFE SCIENCES MASTER FUND LTD EDELMAN JOSEPH 10% Owner | 504,652 | $6.4524 | $3,256,191 | 6,777,566 (Indirect) | View |
2023-12-15 Purchase | 2023-12-19 5:52 pm | Verrica Pharmaceuticals Inc. | VRCA | PERCEPTIVE ADVISORS LLC PERCEPTIVE LIFE SCIENCES MASTER FUND LTD EDELMAN JOSEPH 10% Owner | 1,233,931 | $5.6257 | $6,941,716 | 6,272,914 (Indirect) | View |
2023-11-14 Sale | 2023-11-16 4:49 pm | Verrica Pharmaceuticals Inc. | VRCA | Bonaccorso Joe Chief Commercial Officer | 32,846 | $2.9437 | $96,689 | 92,392 (Direct) | View |
2023-11-14 Sale | 2023-11-16 4:35 pm | Verrica Pharmaceuticals Inc. | VRCA | Goldenberg Gary Chief Medical Officer | 8,853 | $2.9437 | $26,061 | 86,257 (Direct) | View |
2023-11-14 Sale | 2023-11-16 4:34 pm | Verrica Pharmaceuticals Inc. | VRCA | Kohler Terry Chief Financial Officer | 28,084 | $2.9437 | $82,671 | 34,416 (Direct) | View |
2023-11-14 Sale | 2023-11-16 4:33 pm | Verrica Pharmaceuticals Inc. | VRCA | White Ted President and CEO | 33,699 | $2.9437 | $99,200 | 170,090 (Direct) | View |
2023-11-14 Sale | 2023-11-16 4:32 pm | Verrica Pharmaceuticals Inc. | VRCA | Hayes Christopher G. Chief Legal Officer | 33,699 | $2.9437 | $99,200 | 123,226 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
2024-12-09 Option Award | 2024-12-09 5:18 pm | N/A 2034-12-09 | Verrica Pharmaceuticals Inc. | VRCA | Zawitz David Chief Operating Officer | 950,000 | $0 | 950,000 (Direct) | View |
Ownership | 2024-12-09 5:17 pm | N/A N/A | Verrica Pharmaceuticals Inc. | VRCA | Zawitz David Chief Operating Officer | 0 | $0 | 110,000 (Direct) | View |
2024-11-26 Gift | 2024-11-26 4:15 pm | N/A N/A | Verrica Pharmaceuticals Inc. | VRCA | Rieger Jayson CEO and President | 50,000 | $0 | 1,170,779 (Direct) | View |
2024-11-26 Gift | 2024-11-26 4:15 pm | N/A N/A | Verrica Pharmaceuticals Inc. | VRCA | Stalfort John A III Director | 50,000 | $0 | 2,997,394 (Direct) | View |
2024-11-26 Gift | 2024-11-26 4:15 pm | N/A N/A | Verrica Pharmaceuticals Inc. | VRCA | Manning Paul B Director 10% Owner | 450,000 | $0 | 60,982,127 (Direct) | View |
2024-11-06 Option Award | 2024-11-06 9:04 pm | N/A N/A | Verrica Pharmaceuticals Inc. | VRCA | Kirby John J. Interim CFO | 54,267 | $0 | 54,267 (Direct) | View |
2024-11-06 Option Award | 2024-11-06 9:02 pm | N/A 2034-11-06 | Verrica Pharmaceuticals Inc. | VRCA | Rieger Jayson CEO and President | 2,000,000 | $0 | 2,000,000 (Direct) | View |
Ownership | 2024-11-06 8:59 pm | N/A N/A | Verrica Pharmaceuticals Inc. | VRCA | Rieger Jayson CEO and President | 0 | $0 | 558,983 (Direct) | View |
2024-10-09 Option Award | 2024-10-11 4:15 pm | N/A 2034-10-09 | Verrica Pharmaceuticals Inc. | VRCA | Hayes Christopher G. CHIEF LEGAL OFFICER | 50,000 | $0 | 50,000 (Direct) | View |
2024-09-19 Gift | 2024-09-23 4:15 pm | N/A N/A | Verrica Pharmaceuticals Inc. | VRCA | Manning Paul B Director 10% Owner | 4,459,352 | $0 | 13,805,690 (Indirect) | View |
2024-06-06 Option Award | 2024-06-07 4:15 pm | N/A 2034-06-05 | Verrica Pharmaceuticals Inc. | VRCA | PRYGOCKI MARK A SR Director | 20,000 | $0 | 20,000 (Direct) | View |
2024-06-06 Option Award | 2024-06-07 4:15 pm | N/A 2034-06-05 | Verrica Pharmaceuticals Inc. | VRCA | Eichenfield Lawrence Director | 20,000 | $0 | 20,000 (Direct) | View |
2024-06-06 Option Award | 2024-06-07 4:15 pm | N/A 2034-06-05 | Verrica Pharmaceuticals Inc. | VRCA | Nguyen Diem Director | 20,000 | $0 | 20,000 (Direct) | View |
2024-06-06 Option Award | 2024-06-07 4:15 pm | N/A 2034-06-05 | Verrica Pharmaceuticals Inc. | VRCA | Ballaron Craig Director | 20,000 | $0 | 20,000 (Direct) | View |
2024-03-15 Option Award | 2024-03-19 4:31 pm | N/A 2034-03-15 | Verrica Pharmaceuticals Inc. | VRCA | Hayes Christopher G. CHIEF LEGAL OFFICER | 120,000 | $0 | 243,226 (Direct) | View |
2024-03-15 Option Award | 2024-03-19 4:31 pm | N/A 2034-03-15 | Verrica Pharmaceuticals Inc. | VRCA | Goldenberg Gary CHIEF MEDICAL OFFICER | 120,000 | $0 | 206,257 (Direct) | View |
2024-03-15 Option Award | 2024-03-19 4:31 pm | N/A 2034-03-15 | Verrica Pharmaceuticals Inc. | VRCA | Kohler Terry CHIEF FINANCIAL OFFICER | 120,000 | $0 | 154,416 (Direct) | View |
2024-03-15 Option Award | 2024-03-19 4:31 pm | N/A 2034-03-15 | Verrica Pharmaceuticals Inc. | VRCA | Bonaccorso Joe CHIEF COMMERCIAL OFFICER | 120,000 | $0 | 212,392 (Direct) | View |
2024-03-15 Option Award | 2024-03-19 4:31 pm | N/A 2034-03-15 | Verrica Pharmaceuticals Inc. | VRCA | White Ted PRESIDENT AND CEO | 337,500 | $0 | 507,590 (Direct) | View |
2023-08-24 Option Award | 2023-08-28 4:40 pm | N/A N/A | Verrica Pharmaceuticals Inc. | VRCA | Kohler Terry Chief Financial Officer | 62,500 | $0 | 62,500 (Direct) | View |
2023-08-24 Option Award | 2023-08-28 4:39 pm | N/A N/A | Verrica Pharmaceuticals Inc. | VRCA | White Ted President and CEO | 75,000 | $0 | 203,789 (Direct) | View |
2023-08-24 Option Award | 2023-08-28 4:39 pm | N/A N/A | Verrica Pharmaceuticals Inc. | VRCA | Hayes Christopher G. Chief Legal Officer | 75,000 | $0 | 156,925 (Direct) | View |